Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Ramifications of changes we are seeing. The methodology of RG is nice to see.

What investors are going to like is that RG is building a real company from the ground up that has a future beyond the MMP. This is exciting to be on the ground floor of what we all hope will grow into a big company thats a houshold name with multiple millions in revenue year over year. Most of us came here because of the potential of the MMP alone. Once recertification is achieved on the 148 and 336 patents, the MMP will be the catalist that propells this company to new hieghts with more revenue to aquire more technology and grow this company much more for the future.

I believe this company is in a much better position now than when it was trading over $2.00 to actually be somthing. The management is better and the aquisitions diversify the revenue base. As we saw from the pop PTSC had to $2.25 emotion can propell the stock to great heights with great news. Anything could happen a positive revalidation of the patents may not get us to a $1.00 but it also could get us to $3.00. None of us know for sure.

All the best,

Steve

Share
New Message
Please login to post a reply